Key Takeaways Semaglutide, Tirzepatide, and Retatrutide are GLP-1 (glucagon-like peptide-1) medications, each offering increasing efficacy through multi-receptor targeting
In studies examining diet composition effects, Melanotan II most strongly inhibited caloric intake in rats consuming high-fat diets, with fat intake being the most suppressed dietary component
Most GI symptoms peak between weeks 6 and 8 and resolve by week 12
We have highlighted that adapted invitro measurements may help to better understand the importance and interactions between human handling errors and device performance, and that a particular emphasis should be placed on the training of patients against critical inhaler handling errors, as some of the invitro reproduced errors have shown to lead to a drastic decrease of device performance, both on the Emitted Dose (ED) and on the Aerodynamic Particle Size Distribution (APSD) performance of the device, which can therefore significantly impact the success of the treatment
Bariatric surgery offers a safer, more reliable solution with a well-documented safety profile and long-term benefits